Literature DB >> 2857310

Pathological and positron emission tomographic correlations in Alzheimer's disease.

R P Friedland, A Brun, T F Budinger.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 2857310     DOI： 10.1016/s0140-6736(85)92074-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  25 in total

1.  Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects.

Authors:  Nikolaos Scarmeas; Eric Zarahn; Karen E Anderson; John Hilton; Joseph Flynn; Ronald L Van Heertum; Harold A Sackeim; Yaakov Stern
Journal:  Neuroimage       Date:  2003-07       Impact factor: 6.556

Review 2.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

Review 3.  Exploring the neural basis of cognitive reserve in aging.

Authors:  Jason Steffener; Yaakov Stern
Journal:  Biochim Biophys Acta       Date:  2011-09-29

4.  Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.

Authors:  Roger L Albin; Robert A Koeppe; James F Burke; Bruno Giordani; Michael R Kilbourn; Sid Gilman; Kirk A Frey
Journal:  Arch Neurol       Date:  2010-04

5.  Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease.

Authors:  Elena Rodriguez-Vieitez; Antoine Leuzy; Konstantinos Chiotis; Laure Saint-Aubert; Anders Wall; Agneta Nordberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

6.  EEG brain mapping in evaluating the time-course of the central action of DUP 996--a new acetylcholine releasing drug.

Authors:  B Saletu; A Darragh; P Salmon; R Coen
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

Review 7.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

8.  Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance.

Authors:  Nikolaos Scarmeas; Christian G Habeck; Eric Zarahn; Karen E Anderson; Aileen Park; John Hilton; Gregory H Pelton; Matthias H Tabert; Lawrence S Honig; James R Moeller; Davangere P Devanand; Yaakov Stern
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

Review 9.  Cognitive reserve in ageing and Alzheimer's disease.

Authors:  Yaakov Stern
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

Review 10.  APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

Authors:  Andrew B Wolf; Richard J Caselli; Eric M Reiman; Jon Valla
Journal:  Neurobiol Aging       Date:  2012-11-16       Impact factor: 4.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.